Atrogi Announces Positive Clinical Data from First-in-Class Insulin-Independent Treatment for Type 2 Diabetes
Atrogi, a pioneering clinical-stage biotech company advancing treatments for metabolic disorders, announces the full set of results from its Phase 1 a/b trial with ATR-258, its first-in-class treatment for type 2 diabetes (T2D). This clinical trial, conducted on both healthy…
Agilus Diagnostics publishes data study ahead of World Diabetes Day 2023
India has emerged as the diabetes capital of the world with incidence steadily on the rise over the last three decades. The prevalence of diabetes in India stood at 8.9% in 2019 with more than 77 million people with diabetes….
The Inner Circle Acknowledges, , Lawrence J. Singerman as a Most Trusted Healthcare Professional for his contributions to the Field of Ophthalmology
The Inner Circle Acknowledges, , Lawrence J. Singerman as a Most Trusted Healthcare Professional for his contributions to the Field of Ophthalmology. Dr. Singerman earned a Bachelor of Science degree in Psychology from Case Western Reserve University, and a Medical Degree…
